Review
Published on 28 Sep 2023
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250893
- 3,795 views
- 3 citations
Type at least 3 characters
2,601 articles
Articles
Original Research
Published on 28 Sep 2023
A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1220457
- 2,107 views
Systematic Review
Published on 28 Sep 2023
Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1264961
- 20,357 views
- 7 citations
Review
Published on 28 Sep 2023
Photodynamic therapy and associated targeting methods for treatment of brain cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250699
- 3,375 views
- 9 citations
Original Research
Published on 28 Sep 2023
Aqueous Nyctanthes arbortristis and doxorubicin conjugated gold nanoparticles synergistically induced mTOR-dependent autophagy-mediated ferritinophagy in paclitaxel-resistant breast cancer stem cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1201319
- 2,763 views
- 1 citation
Editorial
Published on 27 Sep 2023
Editorial: Different cell death modes in cancer treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291585
- 826 views
Review
Published on 27 Sep 2023
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1269233
- 2,127 views
- 4 citations
Original Research
Published on 26 Sep 2023
METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1257410
- 2,054 views
- 3 citations
Review
Published on 25 Sep 2023
A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1272546
- 3,346 views
- 15 citations
Review
Published on 25 Sep 2023
The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228985
- 2,919 views
- 2 citations
Review
Published on 25 Sep 2023
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226629
- 3,395 views
- 1 citation
Original Research
Published on 25 Sep 2023
Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1128312
- 2,340 views
- 5 citations
Original Research
Published on 21 Sep 2023
The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1234181
- 1,792 views
- 1 citation
Review
Published on 21 Sep 2023
Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1271321
- 2,955 views
Original Research
Published on 21 Sep 2023
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1271268
- 3,396 views
- 3 citations
Review
Published on 21 Sep 2023
Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1225951
- 3,686 views
- 2 citations